why is cryptocurrency so popular Top searches

China's annual export rate in November was 5.8%, the previous value was 11.20%. China's annual import rate in November was -4.7%, while the previous value was -3.70%.AI application-side concept stocks have been repeatedly sought after by Shensi Electronics with a daily limit of 20CM, and Shensi Electronics with a daily limit of 20CM. Before that, Tianyue Digital Branch went out of 7 days and 5 boards, which was worth buying, cool and smart, Huayang Lianzhong, Tuoersi, Yuncong Technology and Fushi Holdings all rose by more than 5%.According to the data released by Shanghai Steel Union, the price of battery-grade lithium carbonate (in early trading) rose by 200 yuan compared with the previous day, with an average price of 76,450 yuan/ton.

The Nikkei 225 index closed at 39,197.42 points in early trading, up 0.09%.Commercial banks strengthen the marketing of personal pension business. According to combing, the "marketing fever" of personal pension business of ICBC, Agricultural Bank, China Construction Bank, Bank of China, Bank of Communications and other banks and their branches is heating up continuously recently. In addition, some banks have stepped up their efforts to "grab food" from the cake of personal pension business with the help of Internet financial platforms such as Jingdong Finance, and added more customers. The experts interviewed believe that it is an important measure for banks and other institutions to carry out personal pension business to implement the national strategy of actively responding to the aging population, which will help promote the implementation of personal pension policy. For banks, personal pension business can increase customer resources and provide a broader market space for bank wealth management business. (Securities Daily)General Administration of Customs: Import and export of general trade and processing trade increased. According to customs statistics, in the first 11 months, China's general trade import and export was 25.5 trillion yuan, an increase of 3.7%, accounting for 64.1% of China's total foreign trade. Among them, the export was 15.04 trillion yuan, up by 7.9%; Imports reached 10.46 trillion yuan, down 1.8%. In the same period, the import and export of processing trade was 7.22 trillion yuan, up by 3.6%, accounting for 18.1%. Among them, exports were 4.58 trillion yuan, an increase of 1.8%; Imports reached 2.64 trillion yuan, up 6.9%. In addition, China's import and export by bonded logistics was 5.64 trillion yuan, an increase of 13%. Among them, exports were 2.2 trillion yuan, an increase of 10.9%; Imports reached 3.44 trillion yuan, up by 14.4%.

Murdoch's request to modify the control of the family trust was reportedly rejected. According to people familiar with the matter, a probate commissioner in Nevada rejected a request by Rupert Murdoch to hand over the control of his media assets to his eldest son after his death, instead of dividing it equally among his four children. Murdoch, 93, had previously tried to modify a trust holding his family assets, including about 40% voting shares of Flowserve and News Corporation.Notice: The National Health and Wellness Commission held a press conference on December 10th to introduce the situation of "learning and popularizing Sanming's medical reform experience".Significant progress in domestic growth hormone! Jichuan Pharmaceutical Co., Ltd. and Tianjing Biological Co., Ltd. announced that the listing application of Etan long-acting growth hormone was accepted, with a height of 10.76 cm a year, which made significant progress in domestic growth hormone. Today, Tianjing Bio and Jichuan Pharmaceutical jointly announced that the application for marketing biological products of Etan long-acting recombinant human growth hormone injection (hereinafter referred to as "Etan long-acting growth hormone") for treating children's growth hormone deficiency (PGHD) has been accepted by NMPA. As the first and only long-acting growth hormone with fusion protein in the domestic application stage and listed products, this innovative therapy is expected to provide safe, effective and convenient treatment options for children with growth hormone deficiency. Etan long-acting growth hormone adopts innovative hyFc® fusion protein technology, which greatly improves the stability and half-life of the drug by combining human growth hormone with specially designed human immunoglobulin. This patented technology not only ensures the biological activity of growth hormone, but also realizes the long-acting function of growth hormone in the body, thus making Ethan the first fusion protein long-acting growth hormone to be administered once a week.